Drug profile · INN
tezepelumab-ekko
TEZSPIRE
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
tezepelumab-ekko (TEZSPIRE) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
INN tezepelumab-ekko
Brand TEZSPIRE
Route SUBCUTANEOUS
Formulation SOLUTION
Frequently asked questions
What is tezepelumab-ekko?
tezepelumab-ekko (TEZSPIRE) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for tezepelumab-ekko?
TEZSPIRE is a marketed brand name for tezepelumab-ekko. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tezepelumab-ekko?
tezepelumab-ekko has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.